These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9855173)

  • 1. Role of endoscopy in nonsteroidal anti-inflammatory drug clinical trials.
    Kimmey MB
    Am J Med; 1998 Nov; 105(5A):28S-31S. PubMed ID: 9855173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A histological study of the effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on the gastric and duodenal mucosa.
    Moghal N; Jafarey NA
    J Pak Med Assoc; 1989 Nov; 39(11):287-90. PubMed ID: 2516535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The availability of prostaglandin derivatives in a treatment and prevention for gastrointestinal mucosal injury].
    Harada S; Takeuchi T; Edogawa S; Ota K; Kojima Y; Higuchi K
    Nihon Rinsho; 2015 Jul; 73(7):1153-8. PubMed ID: 26165072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sucralfate treatment of nonsteroidal anti-inflammatory drug-induced gastrointestinal symptoms and mucosal damage.
    Caldwell JR; Roth SH; Wu WC; Semble EL; Castell DO; Heller MD; Marsh WH
    Am J Med; 1987 Sep; 83(3B):74-82. PubMed ID: 3310631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic aspects of gastroduodenal mucosa due to NSAIDs.
    Ruina M; Caselli M; Sartori S; Trevisani L; La Corte R; Trotta F; Alvisi V
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():9-11. PubMed ID: 9032574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD; Stetsko PI; Sirko SP; Debski S
    J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of nonsteroidal anti-inflammatory drug-related upper gastrointestinal toxicity.
    Soll A
    Am J Med; 1998 Nov; 105(5A):10S-16S. PubMed ID: 9855170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endoscopic changes in the stomach and duodenal mucosa caused by microdose acetylsalicylic acid therapy and their prevention--editorial].
    Ehrmann J; Procházka V; Konecný M; Spacek M; Urbánek K
    Vnitr Lek; 2007 Oct; 53(10):1024-8. PubMed ID: 18072422
    [No Abstract]   [Full Text] [Related]  

  • 9. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use.
    Larkai EN; Smith JL; Lidsky MD; Graham DY
    Am J Gastroenterol; 1987 Nov; 82(11):1153-8. PubMed ID: 3499815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and prevention of nonsteroidal anti-inflammatory drug induced gastrointestinal mucosal injury.
    Agrawal NM; Dajani EZ
    Int J Clin Pharmacol Res; 1989; 9(6):347-57. PubMed ID: 2576801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsteroidal anti-inflammatory drugs: how do they damage gastroduodenal mucosa?
    Scarpignato C
    Dig Dis; 1995 Jan; 13 Suppl 1():9-39. PubMed ID: 7697906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsteroidal anti-inflammatory drugs and ulcers.
    Soll AH
    West J Med; 1992 Oct; 157(4):465-8. PubMed ID: 1462553
    [No Abstract]   [Full Text] [Related]  

  • 13. Protecting the stomach from the "toxins" of NSAIDS and anti-platelet agents.
    Echelmeyer S; Kanwal F
    Mo Med; 2009; 106(5):343-5. PubMed ID: 19902714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: non-steroidal anti-inflammatory drug-induced gastrointestinal permeability.
    Davies NM
    Aliment Pharmacol Ther; 1998 Apr; 12(4):303-20. PubMed ID: 9690719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
    ;
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease.
    Soll AH; Weinstein WM; Kurata J; McCarthy D
    Ann Intern Med; 1991 Feb; 114(4):307-19. PubMed ID: 1987878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NSAID, ulcers, and prostaglandins.
    Kimmey MB
    J Rheumatol Suppl; 1992 Nov; 36():68-73. PubMed ID: 1474538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G; Lazzaroni M; Petrillo M
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention and treatment of upper gastrointestinal bleeding by nonsteroidal anti-inflammatory drugs].
    Bar-Dayan Y; Levi Y
    Harefuah; 1996 Apr; 130(8):535-7. PubMed ID: 8765878
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostaglandins, NSAIDS, and GI mucosal integrity: can we identify patients at risk of NSAID-induced gastric injury?
    Dajani EZ
    Am J Gastroenterol; 1996 May; 91(5):835-6. PubMed ID: 8633566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.